Evidence map›Paper›PMID 18463210›Full record

ArticleJournal of clinical microbiology2008

Epidemiology of severe Streptococcus pyogenes disease in Europe.

Theresa L Lamagni, Jessica Darenberg, Bogdan Luca-Harari, Tuula Siljander, Androulla Efstratiou, Birgitta Henriques-Normark, Jaana Vuopio-Varkila, Anne Bouvet, Roberta Creti, Kim Ekelund and 8 more

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Interventions for necrotizing soft tissue infections in adults.The Cochrane database of systematic reviews · 2018
    Pooled it
  4. Pooled it
  5. Linezolid versus vancomycin for skin and soft tissue infections.The Cochrane database of systematic reviews · 2016
    Pooled it
  6. Chinese herbal medicines for treating skin and soft-tissue infections.The Cochrane database of systematic reviews · 2014
    Pooled it
  7. Predominance of M1European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  8. Observational
  9. Article
  10. Burden of invasive group a streptococcus infection in Australia: a systematic review and meta-analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Theresa L LamagniHealth Protection Agency Centre for Infections, London, United Kingdom.
Jessica Darenberg
Bogdan Luca-Harari
Tuula Siljander
Androulla Efstratiou
Birgitta Henriques-Normark
Jaana Vuopio-Varkila
Anne Bouvet
Roberta Creti
Kim Ekelund
Maria Koliou
Ralf René Reinert
Angeliki Stathi
Lenka Strakova
Vasilica Ungureanu
Claes Schalén
Strep-EURO Study Group
Aftab Jasir

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The past 2 decades have brought worrying increases in severe Streptococcus pyogenes diseases globally. To investigate and compare the epidemiological patterns of these diseases within Europe, data were collected through a European Union FP-5-funded program (Strep-EURO). Prospective population-based surveillance of severe S. pyogenes infection diagnosed during 2003 and 2004 was undertaken in 11 countries across Europe (Cyprus, the Czech Republic, Denmark, Finland, France, Germany, Greece, Italy, Romania, Sweden, and the United Kingdom) using a standardized case definition. A total of 5,522 cases were identified across the 11 countries during this period. Rates of reported infection varied, reaching 3/100,000 population in the northern European countries. Seasonal patterns of infection showed remarkable congruence between countries. The risk of infection was highest among the elderly, and rates were higher in males than in females in most countries. Skin lesions/wounds were the most common predisposing factor, reported in 25% of cases; 21% had no predisposing factors reported. Skin and soft tissue were the most common foci of infection, with 32% of patients having cellulitis and 8% necrotizing fasciitis. The overall 7-day case fatality rate was 19%; it was 44% among patients who developed streptococcal toxic shock syndrome. The findings from Strep-EURO confirm a high incidence of severe S. pyogenes disease in Europe. Furthermore, these results have identified targets for public health intervention, as well as raising awareness of severe S. pyogenes disease across Europe.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsAnimalsCellulitisChildChild, PreschoolEuropeFasciitis, NecrotizingFemaleGeographyHumansIncidenceInfant

Identifiers

PMID18463210
PMCPMC2446932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.